In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 35 for your search:
Cancer Type/Condition:  Breast cancer, female
Stage/Subtype:  inflammatory breast cancer
Trial Type:  All
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000513169, WHC-MRI-GU-2006-097, NCT00397761

2.

Phase: Phase III
Type: Diagnostic
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: R05-0076, NCT00207298

3.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRCA-CCTC-WCTU-ARTemis, CCTC-WCTU-ARTemis, ISRCTN68502941, EUDRACT-2008-002322-11, EU-21017, MREC-08/H1102/104, NCT01093235

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: KBCtrial, NCT01806259

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 105-08-201, NCT00826085

6.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NUALA-01, STU00041525, NCT01313117

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: Over 18
Sponsor: Other
Protocol IDs: 13C.387, 2013-035, NCT01938833

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0903-882, 0309006307, NCT00195091

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: LJCC 07-03, NCT00542191

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NSABP FB-7, NCT01008150

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0372, NCI-2012-00935, NCT01036087

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 097517, NCT01042379

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-0296, NCI-2011-00299, NCT01262027

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: TAME-01, NCT01329627

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 041001, NCI-2011-01124, P30CA072720, NCT01417286

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 11174, NCI-2012-00025, NCT01525966

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-024, NCT01562873

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NAC CCAM 11-01, NCT01641406

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-497, NCT01796197

20.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 30 to 80
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98213, U10CA081851, 1R01HL118740-01, NCT01988571

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C4-08-001, NCT00891280

22.

Phase: No phase specified
Type: Diagnostic, Natural history/Epidemiology
Status: Active
Age: 20 to 39
Sponsor: Other
Protocol IDs: 9361700630, NCT00155038

23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Approved-not yet active
Age: Not specified
Sponsor: Other
Protocol IDs: ProtHYMC, NCT00419627

24.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 2006-1072, NCT00477100

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: BernLCyto-Cog, NCT00756132
1   
New Search